Pediatrics | 8 Oct 2017
SG Robison, AG Dunn, DL Richards and RF Leman
Before the start of the 2016-2017 influenza season, the Advisory Committee on Immunization Practices withdrew its recommendation promoting the use of live attenuated influenza vaccines (LAIVs). There was concern that this might lessen the likelihood that those with a previous LAIV would return for an injectable influenza vaccine (IIV) and that child influenza immunization rates would decrease overall.
* Data courtesy of Altmetric.com